Population Pharmacokinetics of Inotuzumab Ozogamicin (InO) As Single Agent in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia - Results from the ITCC-059 Phase IA and Phase II Trial
Edoardo Pennesi(Princess Máxima Center), C. Michel Zwaan(Hôpital Saint-Michel), Yilin Jiang(Princess Máxima Center), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin), Inge M. van der Sluis(Princess Máxima Center), Franco Locatelli(Bambino Gesù Children's Hospital), Susana Rives(Hospital Sant Joan de Déu Barcelona), Fanny Rialland(Hôpital Mère-Enfant), Christiane Chen‐Santel(Universitätsmedizin Rostock), Gernot Engstler(St Anna Children's Hospital), Jan Starý(Charles University), Anneke C. J. Ammerlaan(Princess Máxima Center), Arnaud Petit(Sorbonne Université), Uta Dirksen(Essen University Hospital), Geneviève Plat(Centre Hospitalier Universitaire de Toulouse), Francisco Bautista(Princess Máxima Center), Carmelo Rizzari(Hôpital Saint-Michel), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Erica Brivio(Princess Máxima Center), Lucie Šrámková(University Hospital in Motol), Kathleen Pelletier(Pfizer (United States)), Bella Bielorai, May Garrett(Pfizer (United States)), Alba Rubio‐San‐Simón(Hospital del Niño), Yives Bertrand(Lyon 1 Université), Aengus O’Marcaigh(Children's Health Ireland at Crumlin), Karsten Nysom(Copenhagen University Hospital), Ying Chen(Qingdao University), Bénedicte Bruno(Centre Hospitalier Universitaire de Lille), Benoît Brethon(Hôpital Saint-Louis), Barbara Sleight(Pfizer (United States)), Alwin D. R. Huitema(The Netherlands Cancer Institute)
Cited by 3
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724